UHS Filings — Universal Health Services, Inc. - FilingSpy
UHS
Universal Health Services, Inc.
A hospital operator running two kinds of care: acute care hospitals offering general surgery, emergency care, and oncology, and behavioral health facilities providing inpatient and outpatient mental health services. UHS operates hundreds of inpatient and outpatient facilities across the U.S., the U.K., and Puerto Rico, and employs roughly one hundred thousand people. Its Alan B. Miller Medical Center is one of its flagship facilities.
UHS Q2 2026 revenue rose 8.3% to $4.64B, but EPS growth slowed sharply as a $28M liability reserve charge and acquisition financing costs weighed on the bottom line.
growth held steady, but earnings momentum slowed. Revenue rose 8.3% to $4.64B and rose 10.1% to $5.98, a deceleration from the 27.5% growth a year ago, as a $28M charge to increase self-insured liability reserves and higher from new debt offset volume gains. The company is preparing to close the $835M Talkspace acquisition next quarter, adding just as Medicaid funding faces a legislated $500M annual cut.
Key takeaways
Consolidated net revenues rose 8.3% to $4.64B, driven by growth of 8.2% in acute care and 7.4% in behavioral health.
rose only 3.3% to $516.7M and narrowed 0.5 points to 11.1%, as a $28M charge to increase pressured results.
Behavioral health income before taxes grew 9% to $427M, supported by a 7.1% increase in net per adjusted admission.
Section summaries
Management's Discussion and Analysis
Q2 2026 net revenues rose 8.3% to $4.64B driven by Same Facility growth in acute and behavioral segments, while income before taxes edged up 1% to $479M.
⌄
Consolidated net revenues increased 8.3% to $4.64B, primarily from a $322M gain across acute care and behavioral health services.
Acute care income before taxes rose 7% to $246M, helped by a 2.9% increase in and lower salaries as a percentage of .
rose, reflecting the April 2026 credit agreement amendment that added $900M in borrowing capacity to fund the pending $835M Talkspace acquisition, expected to close in Q3 2026.
The company disclosed that the One Big Beautiful Bill Act is expected to reduce its annual net benefit from state Medicaid supplemental payment programs by approximately $500M by 2032, beginning in state fiscal year 2028.
What changed
The 10.1% growth in Q2 2026 marks a clear deceleration from the 27.5% EPS growth in Q2 2025, as the $28M liability reserve charge and rising from acquisition financing offset gains.
fell 19.2% to $443.3M, continuing the pressure flagged in prior quarters from higher tied to Medicaid directed payments and new hospitals.
The Talkspace acquisition, announced in Q1 2026, moved closer to closing with the April 2026 credit agreement amendment adding $900M in borrowing capacity, introducing new integration and risks.
The One Big Beautiful Bill Act's estimated $500M annual Medicaid supplemental payment reduction by 2032 quantifies a risk first flagged in FY 2025, now with a specific dollar impact disclosed.
What to watch
Q3 2026 closing of the $835M Talkspace acquisition and the resulting increase in and from the $900M amendment.
Q3 2026 behavioral health income before taxes after the 9% Q2 rise, to see if 7.1% -per-admission growth holds against staffing cost increases.
Resolution of the Nevada $500M verdict and Pavilion/Cumberland appeals, and whether the remaining 2020 insurance coverage is exhausted by pending claims.
Q3 2026 trajectory as continues toward the $950M–$1.1B full-year guide and Medicaid supplemental payment delays persist.
Acute care net revenues grew 8.2% to $2.51B, with income before taxes up 7% to $246M, aided by a 2.9% rise in and lower salaries as a percentage of .
Behavioral health net revenues rose 7.4% to $1.93B, and income before taxes increased 9% to $427M, supported by a 7.1% increase in net per adjusted admission.
A $28M charge to increase was recorded, split between acute care ($17M) and behavioral health ($11M) segments.
The company expects the One Big Beautiful Bill Act to reduce its annual net benefit from state Medicaid supplemental payment programs by approximately $500M by 2032, beginning in state fiscal year 2028.
Liquidity remained strong with $845M in , and the company amended its credit agreement to add $900M in borrowing capacity, partly to fund the planned $835M acquisition of Talkspace.
Quantitative and Qualitative Disclosures About Market Risk
There have been no material changes in the quantitative and qualitative disclosures about market risk during the six months ended June 30, 2026. Reference is made to Item 7A. Quantitative and Qualitative Disclosures About Market Risk in our Annual Report on Form 10-K for the yea…
⌄
There have been no material changes in the quantitative and qualitative disclosures about market risk during the six months ended June 30, 2026. Reference is made to Item 7A. Quantitative and Qualitative Disclosures About Market Risk in our Annual Report on Form 10-K for the year ended December 31, 2025.
See Note 6 to the Condensed Consolidated Financial Statements-Commitments and Contingencies to our condensed consolidated financial statements in Item 1 of Part I of this report for a description of our legal proceedings. Such information is hereby incorporated by reference.
⌄
See Note 6 to the Condensed Consolidated Financial Statements-Commitments and Contingencies to our condensed consolidated financial statements in Item 1 of Part I of this report for a description of our legal proceedings. Such information is hereby incorporated by reference.
Risks center on the pending $835M Talkspace acquisition, physician retention, and a contested D.C. physician-group restructuring under regulatory review.
⌄
The $835M Talkspace acquisition may not close, could be delayed, or may face regulatory conditions that reduce expected , while integration challenges and financing costs add further risk.
Failure to retain Talkspace’s providers, payor relationships, or key employees could undermine the deal’s value and disrupt ongoing operations.
The company’s hospital performance depends on recruiting and retaining quality physicians who control admissions; losing key physicians could materially reduce .
A newly formed physician entity (CMG) now operates under the company’s management, but the D.C. Attorney General is reviewing the transaction and could unwind or alter it, threatening the District Hospitals’ financial performance.
If the CMG restructuring is rejected or materially changed, the anticipated benefits may not materialize, potentially causing a on consolidated results.